Suppr超能文献

血小板上糖蛋白IIb/IIIa(α(IIb)β3)的激活会上调CD40L,并触发内皮细胞依赖CD40L的基质降解。

Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells.

作者信息

May Andreas E, Kälsch Thorsten, Massberg Steffen, Herouy Yared, Schmidt Roland, Gawaz Meinrad

机构信息

Medizinische Klinik, Klinikum rechts der Isar and Deutsches Herzzentrum, Technische Universität München, Germany.

出版信息

Circulation. 2002 Oct 15;106(16):2111-7. doi: 10.1161/01.cir.0000033597.45947.0f.

Abstract

BACKGROUND

CD40L-CD40 interactions induce inflammatory signals in cells of the vascular wall. We evaluated the effects of glycoprotein (GP) IIb/IIIa (alpha(IIb)beta3) engagement that occurs during platelet-endothelium interactions on CD40L surface exposure on platelets and initiation of proteolytic activity in human umbilical vein endothelial cells (HUVECs).

METHODS AND RESULTS

Transient (60-minute) adhesion of thrombin-prestimulated platelets enhanced HUVEC expression of urokinase-type plasminogen activator receptor and membrane type-1 matrix metalloproteinase (MT1-MMP) (reverse transcriptase-polymerase chain reaction, flow cytometry) and secretion of urokinase-type plasminogen activator, tissue-type plasminogen activator, and MMP-1 (ELISA) and induced proteolytic activity via MMP-2 and MMP-9 (gelatin zymography). These effects were abrogated by hindrance of physical platelet-endothelial contacts using transwell systems or inhibited by GRGDSP, mAbs anti-GP IIb/IIIa (7E3), anti-alpha(v)beta3 (LM609), or anti-CD40L (TRAP1). In addition, MMP-2 and MMP-9 were inhibited by specific GP IIb/IIIa antagonists tirofiban, lamifiban, or integrelin. On endothelial cells, induction of proteolytic activity by activated platelets was mimicked by CD40 engagement using soluble CD40L but not affected by antibody clustering of alpha(v)beta3. On platelets, CD40L and CD62P exposure was enhanced on adhesion to HUVECs or immobilized fibrinogen and was abrogated by GRGDSP or LM609. In suspension, cross-linking of GP IIb/IIIa by fibrinogen plus secondary mAb upregulated CD40L surface exposure. Consistently, bivalent mAb 7E3 upregulated CD40L, whereas ligation of GP IIb/IIIa by soluble fibrinogen alone or monovalent Fab-fragment c7E3 had no effect.

CONCLUSIONS

Platelet adhesion via GP IIb/IIIa upregulates CD40L and CD62P surface exposure. Proteolytic activity of HUVEC is induced by the concerted action of beta3-integrin-mediated platelet adhesion and subsequent CD40L-induced signals in HUVECs. Effective anti-GP IIb/IIIa or anti-CD40L strategies might, therefore, contribute to plaque stabilization.

摘要

背景

CD40L-CD40相互作用可诱导血管壁细胞产生炎症信号。我们评估了血小板与内皮细胞相互作用过程中发生的糖蛋白(GP)IIb/IIIa(α(IIb)β3)结合对血小板表面CD40L暴露以及人脐静脉内皮细胞(HUVECs)中蛋白水解活性启动的影响。

方法与结果

凝血酶预刺激血小板的短暂(60分钟)黏附增强了HUVEC中尿激酶型纤溶酶原激活物受体和膜型1基质金属蛋白酶(MT1-MMP)的表达(逆转录聚合酶链反应、流式细胞术)以及尿激酶型纤溶酶原激活物、组织型纤溶酶原激活物和MMP-1的分泌(酶联免疫吸附测定),并通过MMP-2和MMP-9诱导蛋白水解活性(明胶酶谱法)。使用转运小室系统阻碍血小板与内皮细胞的物理接触可消除这些作用,或被GRGDSP、抗GP IIb/IIIa单克隆抗体(7E3)、抗α(v)β3单克隆抗体(LM609)或抗CD40L单克隆抗体(TRAP1)抑制。此外,特异性GP IIb/IIIa拮抗剂替罗非班、拉米非班或依替巴肽可抑制MMP-2和MMP-9。在内皮细胞上,使用可溶性CD40L进行CD40结合可模拟活化血小板诱导的蛋白水解活性,但不受α(v)β3抗体聚集的影响。在血小板上,黏附于HUVECs或固定化纤维蛋白原时CD40L和CD62P的暴露增强,并被GRGDSP或LM609消除。在悬浮液中,纤维蛋白原加二抗单克隆抗体对GP IIb/IIIa的交联上调了CD40L的表面暴露。同样,二价单克隆抗体7E3上调了CD40L,而单独的可溶性纤维蛋白原或单价Fab片段c7E3对GP IIb/IIIa的连接则无影响。

结论

通过GP IIb/IIIa的血小板黏附上调了CD40L和CD62P的表面暴露。HUVEC的蛋白水解活性是由β3整合素介导的血小板黏附以及随后HUVEC中CD40L诱导的信号协同作用诱导的。因此,有效的抗GP IIb/IIIa或抗CD40L策略可能有助于斑块稳定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验